STALICLA AG
Health Tech / Digital Health · Genève, Geneva
STALICLA AG is a Swiss health tech / digital health company based in Genève, Canton of Geneva, listed in the Swiss commercial register since 2017 (UID CHE-421.223.128).
Board members & signatories
- Durham Lynn
- du Portugal
Registered purpose
recherche, étude, développement, fabrication, promotion et commercialisation de solutions de traitements personnalisées (et notamment de produits et de substances pharmaceutiques et biotechnologiques) dans le domaine de la santé, et plus particulièrement dans le domaine des troubles du spectre autistique et autres troubles idiopathiques neuro-développementaux ou non (cf. statuts pour but complet).…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What STALICLA does
OFFERING
STALICLA AG focuses on precision medicine for brain disorders, particularly in the areas of neurodevelopmental and substance use disorders. The company is advancing its drug development pipeline, which includes treatments for Autism Spectrum Disorder (ASD) and other neuropsychiatric conditions, utilizing its DEPI platform for industry partners.
Unlock the full analysis →Similar companies
- Stromal Therapeutics AG — Biotechnology · Basel
- SUBSTIPHARM BIOLOGICS SA — Pharmaceuticals · Plan-les-Ouates
- AL-S Pharma AG — Pharmaceuticals · Schlieren
- Partex.AI Therapeutics AG — Pharmaceuticals · Cham
- Neurimmune AG — Biotechnology · Schlieren
- ADC Therapeutics AG — Biotechnology · Epalinges
Find every health tech / digital health company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned health tech / digital health companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime